Kalambokis et al. [184] demonstrated that rifaximin improves the hemodynamic state and renal function in patients with advanced cirrhosis by significantly reducing CO, increasing systemic vascular resistance, and decreasing plasma renin activity, levels of endotoxin, IL-6, and TNF-α. The gene discussed is TNF; the disease is Cirrhosis.